- Advertisement -spot_img

AUTHOR NAME

Natasha Swift

40 POSTS
0 COMMENTS

Buy these stocks with earnings momentum as market trades at all-time high

Published Fri, Jun 7 202411:43 AM EDTUpdated 5 Min Ago

Apollo’s co-president said it is one of the few private equity firms OK with higher rates

Back in December 2023, when the market was pricing in six or so rate cuts, Apollo Asset Management Co-President Scott Kleinman had a more contrarian view:...

Prosecution rests in Hunter Biden gun trial

Hunter Biden, son of U.S. President Joe Biden, and his wife Melissa Cohen Biden, arrive at the federal court for his trial on criminal...

Here’s where the jobs are for May 2024 — in one chart

Job growth in May was surprisingly strong, pushing back on lingering fears of a broader economic slowdown and likely slowing the Federal Reserve's rate-cutting...

Oscar Health CEO Mark Bertolini is ready to take on the employer market

Mark Bertolini has helped Oscar Health move toward profitability after taking over as CEO of the health insurer a year ago. Now, he says...

El Salvador’s Bukele starts second term amid economic test

By Nelson Renteria SAN SALVADOR (Reuters) - El Salvador's President Nayib Bukele is set to be inaugurated for a second term on Saturday,...

Boeing’s woes a ‘burden’ for entire sector, Airbus executive says

FRANKFURT (Reuters) - Safety and quality problems exposed at Boeing (NYSE:) following a door plug blowout earlier this year risk shaking travellers' confidence...

South Africa election ends three decades of ANC dominance

By Tannur Anders and Sfundo Parakozov JOHANNESBURG (Reuters) -South Africans angry at joblessness, inequality and power shortages have slashed support for the African...

US shifts focus to China risks; Zelenskiy arrives at Asia defence meeting

By Idrees Ali and Xinghui Kok SINGAPORE (Reuters) - U.S. Defense Secretary Lloyd Austin tried to refocus attention on China's threat in the...

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and...

Latest news

- Advertisement -spot_img